摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-2-Benzyl-4-(R)-1,2,3,4-tetrahydro-isoquinolin-3-yl-butyric acid | 882172-41-0

中文名称
——
中文别名
——
英文名称
(R)-2-Benzyl-4-(R)-1,2,3,4-tetrahydro-isoquinolin-3-yl-butyric acid
英文别名
——
(R)-2-Benzyl-4-(R)-1,2,3,4-tetrahydro-isoquinolin-3-yl-butyric acid化学式
CAS
882172-41-0
化学式
C20H23NO2
mdl
——
分子量
309.408
InChiKey
YLECDBJPJQHACE-IEBWSBKVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

反应信息

  • 作为反应物:
    描述:
    (R)-2-Benzyl-4-(R)-1,2,3,4-tetrahydro-isoquinolin-3-yl-butyric acid 在 Pd-BaSO4 N-甲基吗啉氢气1-羟基苯并三唑溶剂黄146盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺三乙胺三氟乙酸 作用下, 以 甲醇二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 37.0h, 生成 N-{3-[(2S,4R)-4-Benzyloxy-1-((R)-2-benzyl-4-(R)-1,2,3,4-tetrahydro-isoquinolin-3-yl-butyryl)-pyrrolidin-2-yl]-propyl}-guanidine
    参考文献:
    名称:
    Synthesis of Tic-d-Phe Ψ[CH2–CH2] isostere and its use in the development of melanocortin receptor agonists
    摘要:
    The first synthesis of Tic-D-Phe Psi[CH2-CH2] isostere is described, which features diastereoselective alkylation of the tricyclic lactam 14. The use of this novel dipeptide isostere in the development of melanocortin agonists has been demonstrated by the synthesis of peptidomimetic 7 and non-peptidic ligand 27. Both compounds displayed significant binding and agonist potency at the MC4R. (C) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.12.005
  • 作为产物:
    描述:
    (3R,11aR)-3-Benzyl-1,2,3,6,11,11a-hexahydro-pyrido[1,2-b]isoquinolin-4-one盐酸 作用下, 反应 24.0h, 以100%的产率得到(R)-2-Benzyl-4-(R)-1,2,3,4-tetrahydro-isoquinolin-3-yl-butyric acid
    参考文献:
    名称:
    Synthesis of Tic-d-Phe Ψ[CH2–CH2] isostere and its use in the development of melanocortin receptor agonists
    摘要:
    The first synthesis of Tic-D-Phe Psi[CH2-CH2] isostere is described, which features diastereoselective alkylation of the tricyclic lactam 14. The use of this novel dipeptide isostere in the development of melanocortin agonists has been demonstrated by the synthesis of peptidomimetic 7 and non-peptidic ligand 27. Both compounds displayed significant binding and agonist potency at the MC4R. (C) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.12.005
点击查看最新优质反应信息